期刊
REGULATORY TOXICOLOGY AND PHARMACOLOGY
卷 37, 期 1, 页码 105-132出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/S0273-2300(02)00019-3
关键词
cancer; risk assessment; biomarkers; 1,3-butadiene; benzene; vinyl chloride; principles
资金
- NCI NIH HHS [P30-CA16086] Funding Source: Medline
- NIEHS NIH HHS [P30ES01896, P42ES05948, ES07126, P30-ES10126, ES11746, R01ES06721, P42 ES004705, P42ES04705] Funding Source: Medline
The estimation and characterization of a cancer risk is grounded in the observation of tumors in humans and/or experimental animals. Increasingly, however, other kinds of data (non-tumor data) are finding application in cancer risk assessment. Metabolism and kinetics, adduct formation, genetic damage, mode of action, and biomarkers of exposure, susceptibility, and effects are examples. While these and other parameters have been studied for many important chemicals over the past 30-40 years, their use in risk assessments is more recent, and new insights and opportunities are continuing to unfold. To provide some perspective on this field, the ILSI Risk Science Institute asked a select working group to characterize the pertinent non-tumor data available for 1,3-butadiene, benzene, and vinyl chloride and to comment on the utility of these data in characterizing cancer risks. This paper presents the findings of that working group and concludes with 15 simple principles for the use of non-tumor data in cancer risk assessment. (C) 2003 Elsevier Science (USA). All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据